
A class action lawsuit has been filed against Athena Cosmetics, Inc. due to allegations that its RevitaLash and RevitaBrow eye serums were marketed as safe cosmetics without adequately disclosing potential eye-related risks tied to a prostaglandin analog ingredient.
The RevitaLash Eye Serum class action case, including Doriann Slattery v. Athena Cosmetics, Inc., Case No. 2:23-cv-10078, and Rebecca Rush v. Athena Cosmetics, Inc., Case No. 2:24-cv-08542-HDV-AJR, was filed in the U.S. District Court for the Central District of California before Judge Hernán D. Vera. The lawsuits began in 2023 and 2024 and were later consolidated for settlement purposes.
Plaintiffs Doriann Slattery, Rebecca Rush, and Corrine Markoff—represented by Honik LLC, Farnese P.C., and Lou Law—alleged violations of state consumer protection statutes, fraud, negligent misrepresentation, breach of warranty, negligence, and unjust enrichment. The RevitaLash Eye Serum legal claims focus on alleged omissions and misleading safety representations.
The case reached a settlement in 2025 establishing a $3.036 million cash fund and a $1.134 million voucher fund.
The latest RevitaLash Eye Serum settlement update from February 2026 confirms a $4,170,000 total resolution in the consolidated lawsuits against Athena Cosmetics, Inc. The RevitaLash Eye Serum lawsuit settlement amount includes a $3,036,000 non-reversionary cash fund and a $1,134,000 voucher fund. The $4.17 million RevitaLash settlement total wasn’t a fine or penalty—it was the result of negotiated compromise. As part of that settlement, Athena agreed to implement specific label changes, update website disclosures and maintain those changes for at least two years
The settlement covers consumers in the United States who purchased RevitaLash Advanced, RevitaLash Advanced Sensitive, RevitaLash Advanced Pro, or RevitaBrow Advanced between January 1, 2017 and preliminary approval. This defines RevitaLash Eye Serum settlement eligibility.
Under the agreement, eligible class members may receive a pro rata cash payment, with additional amounts available for documented purchases, or elect a $110 product voucher.
Many consumers are asking what is the RevitaLash Eye Serum settlement amount per person and how much will they get from RevitaLash Eye Serum lawsuit?
The settlement includes a $3,036,000 cash fund (plus a $1,134,000 voucher fund). Payments are distributed pro rata after fees and administration costs. Claimants in this settlement will receive between $20–$100+ based on factors like total number of claims filed and whether proof of purchase is submitted. A $20 minimum cash floor applies per claimant. With proof, you will recieve a voucher worth $110.
Several factors affect payout including the number of valid claims submitted nationwide, whether you provide proof of purchase (allows multiple-unit claims), election of cash vs. $110 voucher, and administrative costs and court-approved fees
Payments are typically issued 60 days after final court approval scheduled for May 21, 2026. Expect RevitaLash class action settlement payments to be distributed end of July 2026, pending appeals, fraud screening, and verification.
Delays can happen due to court approval processes, appeals, or high claim volumes.
Note that vouchers are non-expiring, transferable, and stackable with promotions. If voucher demand exceeds the cap, cash can be used to fund them — but cash payments cannot drop below $20 per claimant. That $20 floor is unusual and claimant-friendly.
Any unclaimed funds go to City of Hope, a cancer research and treatment center — not back to the company.



What makes the RevitaLash eligibility structure unusually interesting is how tightly it’s engineered around proof, records, and litigation history. Unlike many consumer settlements, claimants who appear in Athena’s internal purchase records can qualify for per-product recovery even without uploading receipts, while those without proof are limited to one benefit per household. The class is also narrowly defined for purchases made for “personal, family, or household purposes,” excluding resellers. There are broader-than-usual carveouts too—anyone with pending litigation against Athena, company insiders, and even certain legal professionals are excluded. And uniquely, the backdrop of prior California injunction litigation adds a regulatory wrinkle not typically seen in cosmetic labeling settlements.
The RevitaLash Eye Serum class action lawsuit alleges that Athena Cosmetics failed to disclose potential risks linked to a prostaglandin analog ingredient in certain lash and brow serums.
Consumers who purchased qualifying RevitaLash or RevitaBrow products in the United States between January 1, 2017 and December 29, 2025 may qualify.
The total RevitaLash Eye Serum settlement is $4,170,000, including a cash fund and a voucher fund.
Payouts are estimated to range from approximately $20 to $100+, depending on the number of claims filed and proof of purchase submitted.
Covered products include RevitaLash Advanced, RevitaLash Advanced Sensitive, RevitaLash Advanced Pro, and RevitaBrow Advanced.
The lawsuit alleged violations of state consumer protection laws, fraud, negligent misrepresentation, breach of warranty, and unjust enrichment.
Proof of purchase is not required for one household claim, but it allows claimants to recover for multiple units.